TP53 and metastatic neoplasm: Similarly, SVs affecting TP53 were more prevalent in metastatic disease (adjusted Δ proportionSV = 0.074, 95% CI: 0.044–0.104, q = 0.060, adjusted Fisher’s Exact test).